Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Breast (Edinburgh, Scotland)
|
November 22, 2016
Factors influencing local control in patients undergoing breast conservation surgery for ductal carcinoma in situ
J Mathew, R Karia, D A L Morgan, et al.
British Journal of Cancer
|
July 17, 2003
Prognostic factors for patients with hepatic metastases from breast cancer
L Wyld, E Gutteridge, S E Pinder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2002
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment
A Howell, J F R Robertson, J Quaresma Albano, et al.
The Journal of Pathology
|
November 5, 2003
Expression of p27kip1 in breast cancer and its prognostic significance
A Barnes, S E Pinder, J A Bell, et al.
The Journal of Pathology
|
October 1, 2008
Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival
J M W Gee, J J Eloranta, J C Ibbitt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2005
Endocrine treatment options for advanced breast cancer--the role of fulvestrant
J F R Robertson, S E Come, S E Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2010
Technical validation of an autoantibody test for lung cancer
A Murray, C J Chapman, G Healey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 10, 2012
The sequential use of endocrine treatment for advanced breast cancer: where are we?
C Barrios, J F Forbes, W Jonat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2012
A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up
S J Johnston, F S Kenny, B M Syed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 31, 2009
Activity of fulvestrant in HER2-overexpressing advanced breast cancer
J F R Robertson, G G Steger, P Neven, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Breast (Edinburgh, Scotland)
|
November 22, 2016
Factors influencing local control in patients undergoing breast conservation surgery for ductal carcinoma in situ
J Mathew, R Karia, D A L Morgan, et al.
British Journal of Cancer
|
July 17, 2003
Prognostic factors for patients with hepatic metastases from breast cancer
L Wyld, E Gutteridge, S E Pinder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2002
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment
A Howell, J F R Robertson, J Quaresma Albano, et al.
The Journal of Pathology
|
November 5, 2003
Expression of p27kip1 in breast cancer and its prognostic significance
A Barnes, S E Pinder, J A Bell, et al.
The Journal of Pathology
|
October 1, 2008
Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival
J M W Gee, J J Eloranta, J C Ibbitt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2005
Endocrine treatment options for advanced breast cancer--the role of fulvestrant
J F R Robertson, S E Come, S E Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2010
Technical validation of an autoantibody test for lung cancer
A Murray, C J Chapman, G Healey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 10, 2012
The sequential use of endocrine treatment for advanced breast cancer: where are we?
C Barrios, J F Forbes, W Jonat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2012
A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up
S J Johnston, F S Kenny, B M Syed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 31, 2009
Activity of fulvestrant in HER2-overexpressing advanced breast cancer
J F R Robertson, G G Steger, P Neven, et al.
Page
of 5